Last edition
News about Industrial talks
Informa Pharma Intelligence announced the 2021 hybrid edition of CPhI and P-Mec conducted by CPhI Conference. The online conference and networking is being held between 15th and 30th Nov 2021, while the in-person event was held between 24th and 26th November, 2021 at India Expo Centre? Greater Noida, according to a statement by Informa
Industrial talks | 27/11/2021 | By Darshana | 195
GlobalData: Indian pharma should grab opportunities to supply oral Covid-19 drugs to global market
The Indian pharma manufacturers may see more demand for oral Covid-19 drugs from various parts of the world, as a larger opportunity in the global supply pool is opening up, says GlobalData, a leading data and analytics company.
Industrial talks | 21/11/2021 | By Darshana | 248
MedGenome and Emmes launch strategic partnership focussed on advancing rare disease research
MedGenome today announced a partnership with Emmes to support the advancement of public health and biopharmaceutical innovation, aimed at accelerating breakthrough treatments, powered by human genomics, for rare disease patients
Industrial talks | 17/11/2021 | By Darshana | 230
Hester Biosciences to acquire 50 per cent stake in Tanzania firm
Hester Biosciences recently said it has entered into a pact to acquire 50 per cent stake in Tanzania-based animal health products distribution firm Thrishool Exim for $2.25 million (around Rs 16 crores)
Industrial talks | 11/11/2021 | By Darshana | 852
NPPA releases draft version of proposed retail price calculation for five formulations
The National Pharmaceutical Pricing Authority (NPPA) has released draft version of proposed retail price calculation for five formulations, including a combination of telmisartan IP 40 mg and amlodipine besylate IP, which has a moving annual total (MAT) of Rs. 596.8 crore.
Industrial talks | 24/10/2021 | By Darshana | 444
The programme will cover pharmacovigilance: basics, objectives & methods, ADRs: Understanding, prevention & reporting, understanding about individual case safety reports (ICSRs), Materiovigilance Programme of India and causality assessment & quality review, signal detection and assessment, and adverse events following immunization (AEFI)
Industrial talks | 18/10/2021 | By Darshana | 442
Indian Pharmacopoeia should be recognised internationally for exporters: FPME
The Federation of Pharmaceutical Merchant Exporters and Allied Products (FPME) wanted the Central government to take initiatives to make Indian Pharmacopoeia to be recognised internationally for exporters and it should be made part of every trade agreement with independent country
Industrial talks | 06/10/2021 | By Darshana | 217
Syntegon to showcase robotics and automation solutions at PACK EXPO 2021
Syntegon Technology presents its latest processing and packaging solutions at PACK EXPO in Las Vegas from September 27 to 29, 2021. The focus of booth C-2800 is on intelligent robotics and automation technologies. Two automated lines and a series of live presentations offer visitors insights into Syntegon's equipment and service portfolio
Industrial talks | 24/09/2021 | By Darshana | 234
Acute shortage of equipments faced by pharma cos: Infomerics
The report reveals that the steep 50 per cent rise in the cost of active pharmaceutical ingredients (API) is pinching the industry hard and raises doubts on the availability of drugs and could lead to shortages, particularly of those that are key in Covid therapy
Industrial talks | 31/08/2021 | By Darshana | 621
Vivera Pharma's ZICOH technology receives second US patent for smart inhaler device
Vivera Pharmaceuticals, an innovative, science-driven pharmaceutical company located in Southern California, has announced that the US Patent and Trademark Office (USPTO) has granted its ZICOH technology a second US Patent, No. 11,090,449
Industrial talks | 30/08/2021 | By Darshana | 295
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy